Public Services Division
Pharmaceutical Research and Manufacturers of America (PhRMA). Represents U.S. pharmaceutical industry research and biotechnology companies. Publishes fact sheets, white papers and other publications that include statistical information.
Bartholow M. Top 200 Drugs of 2012. Pharmacy Times 2013 Jul 13;79(7):42,44. This annual feature includes a table of the top 200 drugs in the U.S. market by total sales in dollars and by total number of prescriptions.
Chow SC, editor. Encyclopedia of Biopharmaceutical Statistics. 3rd ed. rev. New York: Informa Health; 2010. A guide with entries covering statistical design and methods, and updated regulations on regulatory requirements for the pipeline of drug and pharmaceutical product development.
FASTATS: Therapeutic Drug Use. Atlanta: Centers for Disease Control; 2013 - . Includes U.S. data on prescription drug use, and drugs ordered during physician office visits, and hospital outpatient and emergency department visits.
FiercePharma. Top Pharma Companies by 2012 Revenues. Washington (DC): FierceMarkets; 2013 Mar 26. Annual listing from top 10 pharmaceutical manufacturers by sales by a daily pharma business newsletter.
Forbes Global 2000: The World Biggest Public Companies. New York: Forbes: 2013 - . Recommend use Filter by Industry Pharmaceuticals; filters for country and state are also available. Includes data such as sales, profits, assets and market value.
Health Care Cost Institute. Spending on prescriptions in 2011.Washington (DC): Health Care Cost Institute; 2012 Sep. (Issue brief;4). This report includes per capita spending on prescriptions and average price for prescription drugs.
Lucado J; Paez K., Elixhauser A. Medication-Related Adverse Outcomes in U.S. Hospitals and Emergency Departments, 2008. Rockville (MD): Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project ; 2011 Apr. 17 p. (HCUP Statistical Brief;109).
MEPS Topics: Prescription Drugs (Agency for Healthcare Research and Quality). This AHRQ page provides links to data tables and Statistical Briefs on medication use and expenditures.
PAREXEL’s bio/pharmaceutical R & D statistical sourcebook. Boston: PAREXEL International Corp.; c2006 - . Annual. This print resource includes U.S. and international data on drug research and development. Also available as an e-book from Barnett Educational Services.
Pharmaceutical market intelligence reports. West Sussex (UK): Espicom Business Intelligence, 2009 - . Reports available by country within regional sections. Includes country demographics, health care statistics, pharmaceutical and biological pricing, distribution, and market analysis, and some individual company analysis. An abridged version is available annually as the World Pharmaceutical Markets Fact Book, 2004- . Includes Online access requires subscription.
Pharmaceutical statistics: the journal of applied statistics in the pharmaceutical industry. Chichester (UK): Wiley; v.1 -, c2002- . Bimonthly. This journal is the official journal of PSI, Statisticians in the Pharmaceutical Industry, Ltd. It is Indexed in MEDLINE, v.5 - , 2006 - . The MEDLINE title abbreviation is Pharm Stat [ta].
PhRMApedia (Pharmaceutical Research and Manufacturers of America). Search the PhRMA database of reports, press releases, white papers and videos.
Plunkett JW. Health Care Industry Almanac. Houston (TX): Plunkett Research; 1995 - . Includes profiles of the Health Care 500 companies, as well as industry information and selective new pharmaceutical development and drug usage statistics.
Plunkett JW. Plunkett's Biotech & Genetics Industry Almanac. Houston (TX): Plunkett Research; 2000 - . Includes list of Biotech 350 International Companies, as well as industry information and selective new pharmaceutical development and drug usage statistics.
RxList: Internet Drug Index. Top 200 Drugs- U.S. Only. San Clemente (CA): WebMD; 2013. Annual list by RxList of the top drug sales, listed alphabetically by drug name or in order of the number of prescriptions dispensed. Index to the list is in the middle of the page.
U.S. Food and Drug Administration. FY 2012 Innovative Drug Approvals. Silver Spring (MD): U.S. Food and Drug Administration; 2012 Dec. 27 p. FDA report includes data on the number of novel drugs brought to market and timelines for the drug review process.